Prudential Financial Inc Trevena Inc Transaction History

Prudential Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.2 - $0.5 $2,421 - $6,052	-12,105 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.57 - $1.29 $11,628 - $26,317	-20,401 Reduced 62.76%	12,105 $7,000
Q3 2021 Nov 15, 2021	BUY	$1.11 - $1.7 $23,516 - $36,016	21,186 Added 187.16%	32,506 $40,000
Q2 2021 Aug 16, 2021	BUY	$1.46 - $2.25 $16,527 - $25,470	11,320 New	11,320 $19,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $320M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.